Petmed Express(PETS)
$1.07-0.15 (-11.98%)
PETS
Petmed Express financials statements
$1.07
At close:-0.15 (-11.98%)
Want to see PETS full AI Analyst Report?
Petmed Express (PETS) Ratios
879 Followers
Petmed Express Ratios
PETS's free cash flow for Q2 2027 was $-1.64M. For the 2027 fiscal year, PETS's free cash flow was decreased by $-586.00K and operating cash flow was $-1.06M. See a summary of the company’s cash flow.
| Ratios | Mar 26 | Jun 25 | Mar 24 | Mar 23 | Mar 22 |
|---|---|---|---|---|---|
| Liquidity Ratios | |||||
| Current Ratio | 0.84 | 1.26 | 1.30 | 2.27 | 4.55 |
| Quick Ratio | 0.58 | 1.00 | 0.90 | 1.94 | 3.57 |
| Cash Ratio | 0.41 | 0.87 | 0.77 | 1.81 | 3.35 |
| Solvency Ratio | -0.92 | 0.01 | -0.01 | 0.14 | 0.70 |
| Operating Cash Flow Ratio | -0.55 | 0.08 | 0.06 | 0.48 | 0.56 |
| Short-Term Operating Cash Flow Coverage | -57.59 | 10.23 | 9.41 | 0.00 | 0.00 |
| Net Current Asset Value | $ -8.69M | $ 15.30M | $ 20.50M | $ 70.39M | $ 116.86M |
| Leverage Ratios | |||||
| Debt-to-Assets Ratio | 0.01 | 0.01 | 0.01 | 0.01 | 0.00 |
| Debt-to-Equity Ratio | 0.02 | 0.01 | 0.02 | 0.01 | 0.00 |
| Debt-to-Capital Ratio | 0.02 | 0.01 | 0.01 | 0.01 | 0.00 |
| Long-Term Debt-to-Capital Ratio | 0.00 | 0.01 | 0.00 | 0.00 | 0.00 |
| Financial Leverage Ratio | 2.81 | 1.75 | 1.76 | 1.55 | 1.24 |
| Debt Service Coverage Ratio | -44.53 | 2.22 | -0.89 | 0.00 | 0.00 |
| Interest Coverage Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Debt to Market Cap | 0.01 | 0.01 | 0.00 | 0.00 | 0.00 |
| Interest Debt Per Share | 0.03 | 0.05 | 0.07 | 0.05 | 0.00 |
| Net Debt to EBITDA | 0.95 | -8.01 | -68.76 | -9.38 | -3.73 |
| Profitability Margins | |||||
| Gross Profit Margin | 22.81% | 30.46% | 28.35% | 27.68% | 27.55% |
| EBIT Margin | -17.55% | -0.15% | -2.29% | 2.90% | 9.90% |
| EBITDA Margin | -12.30% | 2.96% | 0.29% | 4.28% | 10.90% |
| Operating Profit Margin | -17.55% | -0.67% | -2.54% | 2.55% | 9.40% |
| Pretax Profit Margin | -32.04% | -0.26% | -2.29% | 2.90% | 9.90% |
| Net Profit Margin | -32.00% | -2.76% | -2.72% | 2.00% | 7.72% |
| Continuous Operations Profit Margin | -32.00% | -2.76% | -2.72% | 2.00% | 7.72% |
| Net Income Per EBT | 99.87% | 1068.31% | 118.99% | 69.04% | 77.94% |
| EBT Per EBIT | 182.58% | 38.37% | 90.10% | 113.65% | 105.29% |
| Return on Assets (ROA) | -70.56% | -4.22% | -4.39% | 3.02% | 11.97% |
| Return on Equity (ROE) | -197.95% | -7.37% | -7.72% | 4.67% | 14.84% |
| Return on Capital Employed (ROCE) | -107.74% | -1.78% | -7.12% | 5.82% | 17.96% |
| Return on Invested Capital (ROIC) | -105.82% | -1.77% | -7.09% | 4.02% | 14.00% |
| Return on Tangible Assets | -81.37% | -5.77% | -5.65% | 3.13% | 12.03% |
| Earnings Yield | -120.09% | -7.27% | -7.82% | 1.56% | 4.05% |
| Efficiency Ratios | |||||
| Receivables Turnover | 93.83 | 97.96 | 83.49 | 147.46 | 142.93 |
| Payables Turnover | 6.61 | 6.70 | 5.30 | 7.37 | 7.20 |
| Inventory Turnover | 10.16 | 9.74 | 6.88 | 9.77 | 6.10 |
| Fixed Asset Turnover | 6.67 | 7.61 | 9.76 | 9.80 | 11.18 |
| Asset Turnover | 2.20 | 1.53 | 1.61 | 1.51 | 1.55 |
| Working Capital Turnover Ratio | 46.91 | 12.08 | 5.81 | 2.69 | 2.34 |
| Cash Conversion Cycle | -15.39 | -13.29 | -11.37 | -9.67 | 11.68 |
| Days of Sales Outstanding | 3.89 | 3.73 | 4.37 | 2.48 | 2.55 |
| Days of Inventory Outstanding | 35.94 | 37.47 | 53.07 | 37.36 | 59.80 |
| Days of Payables Outstanding | 55.22 | 54.49 | 68.81 | 49.51 | 50.67 |
| Operating Cycle | 39.83 | 41.20 | 57.45 | 39.84 | 62.36 |
| Cash Flow Ratios | |||||
| Operating Cash Flow Per Share | -1.36 | 0.23 | 0.21 | 1.37 | 0.92 |
| Free Cash Flow Per Share | -1.58 | -0.02 | -0.01 | 1.11 | 0.83 |
| Dividend Paid and CapEx Coverage Ratio | -6.12 | 0.89 | 0.25 | 0.93 | 0.71 |
| Capital Expenditure Coverage Ratio | -6.15 | 0.92 | 0.96 | 5.29 | 10.56 |
| Operating Cash Flow Coverage Ratio | -53.07 | 4.74 | 2.97 | 27.94 | 0.00 |
| Operating Cash Flow to Sales Ratio | -0.16 | 0.02 | 0.02 | 0.11 | 0.07 |
| Free Cash Flow Yield | -69.20% | -0.46% | -0.20% | 6.85% | 3.22% |
| Valuation Ratios | |||||
| Price-to-Earnings (P/E) Ratio | -0.83 | -13.97 | -12.79 | 64.06 | 24.67 |
| Price-to-Sales (P/S) Ratio | 0.27 | 0.38 | 0.35 | 1.28 | 1.90 |
| Price-to-Book (P/B) Ratio | 1.65 | 1.01 | 0.99 | 2.99 | 3.66 |
| Price-to-Free Cash Flow (P/FCF) Ratio | -1.45 | -218.47 | -492.03 | 14.61 | 31.08 |
| Price-to-Operating Cash Flow Ratio | -1.68 | 18.29 | 22.11 | 11.84 | 28.14 |
| Price-to-Earnings Growth (PEG) Ratio | -0.00 | 0.74 | 0.05 | -0.84 | -0.79 |
| Enterprise Value Multiple | -1.22 | 4.86 | 53.14 | 20.58 | 13.74 |
| Enterprise Value | 26.82M | 32.57M | 41.61M | 226.17M | 409.46M |
| EV to EBITDA | -1.22 | 4.86 | 53.14 | 20.58 | 13.74 |
| EV to Sales | 0.15 | 0.14 | 0.15 | 0.88 | 1.50 |
| EV to Free Cash Flow | -0.81 | -82.46 | -214.49 | 10.03 | 24.45 |
| EV to Operating Cash Flow | -0.94 | 6.90 | 9.64 | 8.13 | 22.14 |
| Tangible Book Value Per Share | 0.87 | 2.19 | 2.89 | 5.13 | 7.00 |
| Shareholders’ Equity Per Share | 1.38 | 4.13 | 4.74 | 5.42 | 7.05 |
| Tax and Other Ratios | |||||
| Effective Tax Rate | 0.00 | -9.68 | -0.19 | 0.31 | 0.22 |
| Revenue Per Share | 8.56 | 11.02 | 13.44 | 12.65 | 13.55 |
| Net Income Per Share | -2.74 | -0.30 | -0.37 | 0.25 | 1.05 |
| Tax Burden | 1.00 | 10.68 | 1.19 | 0.69 | 0.78 |
| Interest Burden | 1.83 | 1.78 | 1.00 | 1.00 | 1.00 |
| Research & Development to Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A to Revenue | 0.40 | 0.28 | 0.20 | 0.19 | 0.11 |
| Stock-Based Compensation to Revenue | 0.01 | -0.03 | 0.03 | 0.03 | 0.02 |
| Income Quality | 0.50 | -0.75 | -0.58 | 119.33 | 0.88 |
Currency in USD
